Compare Mutual Funds

Pros
Beats FD returns for both 3Y & 5Y duration.

Beats FD returns for both 3Y & 5Y duration.

Larger AUM within category.

Larger AUM within category.

Beats FD returns for both 3Y & 5Y duration.

Beats FD returns for both 3Y & 5Y duration.

Cons
5Y returns in the bottom 25% of the category.

5Y returns in the bottom 25% of the category.

5Y returns in the bottom 25% of the category.

5Y returns in the bottom 25% of the category.

3Y returns in the bottom 25% of the category.

3Y returns in the bottom 25% of the category.

INDMoney rank
5/8
6/8
Category

Equity, Sector - Healthcare

Equity, Sector - Healthcare

Fund Age

6 Years 10 Months

13 Years 6 Months

Fund AUM

₹859 Cr

₹7898 Cr

Min Investment
  1. SIP ₹100
  2. Lumpsum ₹1000
  1. SIP ₹100
  2. Lumpsum ₹5000
Expense Ratio

1.02%

0.93%

Exit Load

1%

1%

Benchmark Index

BSE Healthcare TR INR

BSE Healthcare TR INR

No of Holdings

39

39

Top 5 Holdings
  1. Sun Pharmaceuticals Industries Ltd(13.42%)
  2. Apollo Hospitals Enterprise Ltd(7.34%)
  3. Torrent Pharmaceuticals Ltd(5.03%)
  4. J.B. Chemicals & Pharmaceuticals Ltd(4.99%)
  5. Aurobindo Pharma Ltd(4.42%)
  1. Sun Pharmaceuticals Industries Ltd(13.92%)
  2. Lupin Ltd(8.45%)
  3. Divi's Laboratories Ltd(6.41%)
  4. Dr Reddy's Laboratories Ltd(5.96%)
  5. Cipla Ltd(5.42%)
No of Sectors

2

1

Top 3 Sectors
  1. Health(99.25%)
  2. Basic Materials(0.75%)

Health

(100%)

Equity %

97.65%

99.46%

Debt %

-

-

P/E

36.85

34.36

P/B

5.51

5.45

Credit Quality

-

-

Modified Duration

-

-

YTM

-

-

1-Month Return

3.72%

4.47%

3-Month Return

8.5%

7.61%

6-Month Return

1.62%

0.72%

1-Year Return

7.24%

5.12%

3-Year Return

24.53%

23.29%

5-Year Return

14.37%

14.67%

Sharpe

1.05

1

Alpha

0.78

-0.11

Beta

0.92

0.91

Standard Deviation

16.07

15.72

Information Ratio

-0.12

-0.48

Description

Aditya Birla Sun Life Pharma & Healthcare Fund is an equity fund.The fund could potentially beat inflation in the long-run.

Nippon India Pharma Fund is an equity fund.The fund could potentially beat inflation in the long-run.

Managers

Dhaval Shah

Amber Singhania, Sailesh Raj Bhan, Kinjal Desai

Most Popular Comparisons